How many clinical trials are there for Thalassemia Alpha?

PlainTrial tracks 1 US clinical trials for Thalassemia Alpha, of which 1 are currently recruiting.

Which interventions appear most often on Thalassemia Alpha trial records?

GWAS is the most-linked intervention name on Thalassemia Alpha records (1 trial links). Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for Thalassemia Alpha?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Thalassemia Alpha clinical trials

Compiled by PlainTrial · August 8, 2026

1 of 1 indexed Thalassemia Alpha trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Thalassemia Alpha: 1 US clinical trial tracked, 1 recruiting.

Thalassemia Alpha is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Cyprus Institute of Neurology and Genetics, running 1 of these trials.

Enrollment posture brief

Registry condition thalassemia-alpha

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Open-enrollment share among volume-matched conditions near Thalassemia Alpha

Thalassemia Alpha lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Thalassemia Alpha on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Thalassemia Alpha is recruiting above its size-band peers.

1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

1 total, page 1 of 1

RECRUITING 30,000 participants

Study of the Role of Genetic Modifiers in Hemoglobinopathies

Cyprus Institute of Neurology and Genetics

NCT05799118

Phase Distribution

Phase data not available

Top Sponsors

Cyprus Institute of Neurology and Genetics 1 trials

Named interventions

Most-linked intervention names on Thalassemia Alpha records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

GWAS Genetic

1 trials

US sites by state

Facility locations filed on Thalassemia Alpha trials. A trial with sites in several states counts in each.

Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Thalassemia Alpha page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

1 Thalassemia Alpha trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
Cyprus Institute of Neurology and Genetics sponsors the most Thalassemia Alpha trials on record, review their full trial history before evaluating a specific study. See Cyprus Institute of Neurology and Genetics's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Thalassemia Alpha condition card totals 1 registered trials; most-linked intervention GWAS; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.